Antitumour characteristics of irinotecan-containing microspheres of poly-d,l-lactic acid or poly(d,l-lactic acid-co-glycolic acid) copolymers

S.T.P. Pharma Sciences

Volumn 8, Issue 3, 1998, Pages 175-181

  Machida, Y ^a,b   Onishi, H ^b   Morikawa, A ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Antitumor effect; Drug release; Irinotecan; Microspheres; Poly(d,l lactic acid co glycolic acid) copolymer; Toxic side effect

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; COPOLYMER; GLYCOLIC ACID; IRINOTECAN; LACTIC ACID; MICROSPHERE; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; LEUKEMIA; MOUSE; NONHUMAN;

EID: 0031797776     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. NITTA K., YOKOKURA T., SAWADA S., KUNIMOTO T., TANAKA T., UEHARA N., BABAH., TAKEUCHI M., MIYASAKA T. and MUTAI M. - Antitumour activity of novel derivatives of camptothecin. - Jpn. J. Cancer Chemother., 14, 850-857, 1987.
2. TSURUO T., MATSUZAKI T., MATSUSHITA M., SAITO H. and YOKOKURA T. - Antitumour effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumours in vitro and in vivo. - Cancer Chemother. Pharmacol., 21, 71-74, 1988.
3. FURUTA T., YOKOKURA T. and MUTAI M. - Antitumour activity of CPT-11 against rat Walker 256 carcinoma. - Jpn. J. Cancer Chemother., 15, 2757-2760, 1988.
4. FURUTA T. and YOKOKURA T. - Effect of administration schedules on the antitumour activity of CPT-11, a camptothecin derivative. - Jpn. J. Cancer Chemother., 17, 121-130, 1990.
5. FURUTA T. and YOKOKURA T. - Combination therapy of CPT-11, a camptothecin derivative, with various antitumour drugs against L1210 leukemia. - Jpn. J. Cancer Chemother., 18, 393-402, 1991.
6. OKADA K. and ANDOH T. - Cancer chemotherapy: Topoisomerases I and II, and the inhibitors to them. - Antibiotics and Chemotherapy, 9, 221-228, 1993.
7. INABA M. - Kinetic analysis of cell-killing action of DNA topoisomerase I and II inihibitors. - In: Abstract of Research Works for the General Research A of Subject Number 05302061 (represented by M. Hanano, 1993-1994), Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, 1994, pp. 57-61.
8. NAGATA H. - Flow cytometric analysis of the effect of an antitumour alkaloid, camptothecin on cell cycle progression of KB cell. - J. Aichi Med. Univ. Assoc., 15, 683-699, 1987.
9. KANEDA N., NAGATA H., FURUTA T. and YOKOKURA T. - Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mice. - Cancer Res., 50, 1715-1720, 1990.
10. KAWATO Y., AONUMA M., HIROTA Y., KUGA H. and SATO K. - Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumour effect of CPT-11. - Cancer Res., 51, 4187-4191, 1991.
11. WAKIYAMA N., JUNI K. and NAKANO M. - Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. - Chem. Pharm. Bull., 29, 3363-3368, 1981.
12. HIRANO M., SAKATOKU M., YAMASHITA R. and IWA T. - Study on slow released anticancer drug with polylactic acid. - Jpn. J. Artif. Organs, 13, 1176-1179, 1984.
13. YAMASHITA R., SAKATOKU M., HIRANO M. and IWA T. - Study on slow releasing anticancer agent, 5FU-polylactic acid compound. - Jpn. J. Artif. Organs, 14, 818-821, 1985.
14. JUNI K., OGATA J., NAKANOM., ICHIHARA T., MORI K. and AKAGI M. - Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. - Chem. Pharm. Bull., 33, 313-318, 1985.
15. OGAWA Y., YAMAMOTO M., TAKADA S., OKADA H. and SHIMAMOTO T. - Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer. - Chem. Pharm. Bull., 36, 1502-1507, 1988.
16. OGAWA Y., OKADA H., YAMAMOTO M. and SHIMAMOTO T. - In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/ glycolic) acids and in vivo degradation of these polymers. - Chem. Pharm. Bull., 36, 2576-2581, 1988.
17. HEYA T., OKADA H., OGAWA Y. and TOGUCHI H. - Factors influencing the profiles of TRH release from copoly(d,I-lactic/ glycolic acid) microspheres. - Int. J. Pharm., 72, 199-205, 1991.
18. GILDING D.K. and REED A.M. - Biodegradable polymers for use in surgery polyglycolic/poly(lactic acid) homo- and copolymers I. - Polymer, 20, 1459-1464, 1979.
19. RIVORY L.P. and ROBERT J. - Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma. - J. Chromatogr, 661, 133-141, 1994.
20. TAKAKURA Y., TAKAGI A., HASHIDA M. and SEZAKI H. - Disposition and tumour localization of mitomycin C-dextran conjugates in mice. - Pharm. Res., 4, 293-300, 1987.
21. HAGIWARA A., TAKAHASHI T., KOJIMA O., YAMAGUCHI T., SASABE T., LEE M., SAKAKURA C., SHOBAYASHI S., IKADA Y. and HYON S.H. - Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. - Cancer, 71, 844-850, 1993.
22. SASABE T. - An experimental study of lacic acid oligomer microspheres incorporating cisplatin administered intraperitoneally. - Journal of Kyoto Prefectual University of Medicine, 103, 339-348, 1994.
23. YOSHIKAWA H., NAKAO Y., TAKADA K., MURANISHI S., WADA R., TABATA Y., HYON S.-H. and IKADA Y. - Targeted and sustained delivery of adarubicin to lymphatics by lactic acid-oligomer microsphere in rat. - Chem. Pharm. Bull., 37, 802-804, 1989.
24. AKAMISAWA S., MURAKAMI M., YOSHIKAWA H., TAKADA K., MURANISHI S., WADA R., TABATA Y., HYON S.H. and IKADA Y. - Lymphotropic and sustained delivery of adarubicin from lactic acid-oligomer microspheres. Effect of molecular weight of lactic acid-oligomer and of size of microspheres. - Drug Delivery System, 6, 35-39, 1991.
25. KANEDA N. and YOKOKURA T. - Non-linear pharmacokinetics of CPT-11 in rats. - Cancer Res., 50, 1721-1725, 1990.